Accès ouvert
2024
article
OpenAlex
Tewodros Mamo, Cheryl A. Cox, Connor Demorest, Magali J. Fontaine et autres
us, au, de
(code pays fourni par la source)
2024
article
OpenAlex
Alpa A. Trivedi, Maximillian Lin, Byron Y. Miyazawa, Alison Nair et autres
us, de, gb
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jeremy Epah, Gabriele Spohn, Kathrin Preiß, Markus Matthias Müller et autres
BACKGROUND: Bone marrow (BM) transplantation is a life-saving therapy for hematological diseases, and the BM harbors also highly useful (progenitor) cell types for novel cell therapies manufacture. Yet, the BM collection technique is not standardized. METHODS: Benchmarking our collection efficiency to BM …
de
(code pays fourni par la source)
2023
article
OpenAlex
Alpa A. Trivedi, Mao Lin, Byron Y. Miyazawa, Ashwin Nair et autres
2023
article
OpenAlex
Hélène Willer, Corinna Thielemann, Susanne Elvers-Hornung, Gabriele Spohn et autres
Accès ouvert
2022
article
OpenAlex
Monica Langiu, Philipp Bechstein, Gabriele Spohn, Erik Maronde
We evaluated the signalling framework of immortalized cells from the hypothalamic suprachiasmatic nucleus (SCN) of the mouse. We selected a vasoactive intestinal peptide (VIP)-positive sub-clone of immortalized mouse SCN-cells stably expressing a cAMP-regulated-element (CRE)-luciferase construct named SCNCRE. We characterized these cells in …
de, au
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Hélène Willer, Gabriele Spohn, Kimberly Morgenroth, Corinna Thielemann et autres
Human Mesenchymal Stromal Cells (hMSCs) are a promising source for cell-based therapies. Yet, transition to phase III and IV clinical trials is remarkably slow. To mitigate donor variabilities and to obtain robust and valid clinical data, we aimed first to develop a …
de, fr
(code pays fourni par la source)
2021
article
OpenAlex
Hélène Willer, Corinna Thielemann, Susanne Elvers-Hornung, Gabriele Spohn et autres
de, fr
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Gabriele Spohn, Anne-Sophie Witte, Anja Kretschmer, Erhard Seifried et autres
Background Mesenchymal stromal cells (MSCs), multipotent progenitors that can be isolated from a variety of different tissues, are becoming increasingly important as cell therapeutics targeting immunopathologies and tissue regeneration. Current protocols for MSC isolation from bone marrow (BM) rely on density gradient …
de
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Salim Oulghazi, Sarah K. Wegner, Gabriele Spohn, Nina Müller et autres
BACKGROUND: The spontaneously diabetic "non-obese diabetic" (NOD) mouse is a faithful model of human type-1 diabetes (T1D). METHODS: Given the pivotal role of α4 integrin (CD49d) in other autoimmune diseases, we generated NOD mice with α4-deficient hematopoiesis (NOD.α4-/-) to study the role …
de, us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Richard Schäfer, Matthias Georg Schwab, Georg Siegel, Andreas von Ameln-Mayerhofer et autres
BACKGROUND: Limited knowledge of stem cell therapies` mechanisms of action hampers their sustainable implementation into the clinic. Specifically, the interactions of transplanted stem cells with the host vasculature and its implications for their therapeutic efficacy are not elucidated. We tested whether adhesion …
de, am, it, us, ch
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Richard Schäfer, Gabriele Spohn, Marco Bechtel, Denisa Bojková et autres
Previous studies reported on the safety and applicability of mesenchymal stem/stromal cells (MSCs) to ameliorate pulmonary inflammation in acute respiratory distress syndrome (ARDS). Thus, multiple clinical trials assessing the potential of MSCs for COVID-19 treatment are underway. Yet, as SARS-inducing coronaviruses infect …
de
(code pays fourni par la source)